These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 31072189)

  • 21. A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials.
    Nowacki AS; Zhao W; Palesch YY
    Stat Methods Med Res; 2017 Jun; 26(3):1078-1092. PubMed ID: 25586325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-randomization tests in clinical trials.
    Proschan MA; Dodd LE
    Stat Med; 2019 May; 38(12):2292-2302. PubMed ID: 30672002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response-adaptive treatment allocation for survival trials with clustered right-censored data.
    Su PF; Cheung SH
    Stat Med; 2018 Jul; 37(16):2427-2439. PubMed ID: 29672881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian response adaptive randomization using longitudinal outcomes.
    Hatayama T; Morita S; Sakamaki K
    Pharm Stat; 2015; 14(5):369-76. PubMed ID: 26099995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical inference for response adaptive randomization procedures with adjusted optimal allocation proportions.
    Zhu H
    J Biopharm Stat; 2017; 27(5):732-740. PubMed ID: 27937121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial.
    Ji L; McShane LM; Krailo M; Sposto R
    Clin Trials; 2019 Dec; 16(6):599-609. PubMed ID: 31581815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Power and sample size simulations for Randomized Play-the-Winner rules.
    Guimaraes P; Palesch Y
    Contemp Clin Trials; 2007 Jul; 28(4):487-99. PubMed ID: 17321219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ordinal probability effect measures for group comparisons in multinomial cumulative link models.
    Agresti A; Kateri M
    Biometrics; 2017 Mar; 73(1):214-219. PubMed ID: 27438478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brick tunnel randomization for unequal allocation to two or more treatment groups.
    Kuznetsova OM; Tymofyeyev Y
    Stat Med; 2011 Apr; 30(8):812-24. PubMed ID: 21432876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of adaptation algorithm, timing, and stopping boundaries on the performance of Bayesian response adaptive randomization in confirmative trials with a binary endpoint.
    Jiang Y; Zhao W; Durkalski-Mauldin V
    Contemp Clin Trials; 2017 Nov; 62():114-120. PubMed ID: 28866294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
    Lin J; Bunn V
    Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomization in clinical studies.
    Lim CY; In J
    Korean J Anesthesiol; 2019 Jun; 72(3):221-232. PubMed ID: 30929415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The asymptotic maximal procedure for subject randomization in clinical trials.
    Zhao W; Berger VW; Yu Z
    Stat Methods Med Res; 2018 Jul; 27(7):2142-2153. PubMed ID: 27856960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing three regularization methods to avoid extreme allocation probability in response-adaptive randomization.
    Du Y; Cook JD; Lee JJ
    J Biopharm Stat; 2018; 28(2):309-319. PubMed ID: 28323532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are outcome-adaptive allocation trials ethical?
    Hey SP; Kimmelman J
    Clin Trials; 2015 Apr; 12(2):102-6. PubMed ID: 25649106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An oncology clinical trial design with randomization adaptive to both short- and long-term responses.
    Liu H; Lin X; Huang X
    Stat Methods Med Res; 2019 Jul; 28(7):2015-2031. PubMed ID: 29233085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A gate-keeping test for selecting adaptive interventions under general designs of sequential multiple assignment randomized trials.
    Zhong X; Cheng B; Qian M; Cheung YK
    Contemp Clin Trials; 2019 Oct; 85():105830. PubMed ID: 31470107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomization in clinical trials: conclusions and recommendations.
    Lachin JM; Matts JP; Wei LJ
    Control Clin Trials; 1988 Dec; 9(4):365-74. PubMed ID: 3203526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Block response-adaptive randomization in clinical trials with binary endpoints.
    Magirr D
    Pharm Stat; 2011; 10(4):341-6. PubMed ID: 22328326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Balancing statistical and ethical considerations in planning clinical trials: recommendations for response-adaptive randomization urn designs.
    Piccorelli AV; Fraker SA
    J Biopharm Stat; 2018; 28(6):1105-1118. PubMed ID: 29442610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.